Question special

As Michael mentioned in his last question, the PRECISION study had a large rate of study drug discontinuation - 68.8% of the patients stopped taking the study drug, and 27.4% of the patients discontinued follow-up. When you are designing and analyzing the results of a clinical trial, how do you take into account loss to follow up in both your statistical analysis as well as your interpretation of the results?